Finance Cost 20.73 26.69 (22.33) Net Profit 192.09 129.08 48.81 (Unit : Million Baht) Financial statements in which equity method is applied 2019 2018 % Change Sales and Service Income 2,055.48 1,892.88
December and the fourth quarter of 2019) Performance Analysis Unit : MB Y2019 Y2018 Change MB % Net sales 1,001.58 1,057.38 (55.80) (5.28) Other income 41.40 47.74 (6.34) (13.28) Total revenues 1,042.98
year were as highlighted below ; (Unit : Million Baht) Q2/2017 Q2/2016 % Change Sales 521 501 4 Gross Profit Margin 24% 29% -5 Selling and Administrative Expenses 53 55 -4 Financial Cost 8 9 -11 Net
Cash Equivalent on 1st January 60.6 76.8 Net Cash Provided (Used in) Operating Activities 26.9 24.4 Net Cash Provided (Used in) Investing Activities (0.8) (79.8) Net Cash Provided (Used in) Financing
Microsoft Word - MD&A 2Q17 EN August 15, 2017 To President, The Stock Exchange of Thailand Subject Notification on the difference of revenue from sales and net profit YOY by more than 20 percent
THB 6.05 million or increased by 0.68% from 3Q2016. In accordance with all reasons above, it drove net profit to perform at THB 505.71 million or increased by 2.03% from 3Q2016. The EPS of 3Q2017 was
management which we have more focused in this year. Income 221.39 Cost of goods sold 180.03 Gross Profit Margin 37.27 Administration expenses 12.85 Selling expenses 3.59 Net Profit Margin 18.31 Profit (Baht
incurred from deferred tax. This extra transaction was included in year ended 2017 financial statement for the net amount of THB 24 million. Revenue from Hospital Operations Revenue from hospital operations
) 19.58 0.12 (205.69) (1.21) (219.32) (1.27) Profit for The Year 1,213.14 7.26 1,656.47 9.73 1,757.93 10.20 Non - Controlling Interests (18.22) (0.11) (12.77) (0.07) (9.58) (0.06) Net Profit 1,194.92 7.15
Company’s net tangible assets. Thus, the Company and its subsidiaries do not have any disposal transaction on any assets of the Company and its subsidiaries for the last 6 months. The details of transaction